Results 121 to 130 of about 14,011 (208)

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad. [PDF]

Malar J
Grandesso F, Diar MSI, Kouassi F, Sayyad-Hilario J, Ouedraogo P, Djimde AA, Singh S, Dama S.   +7 more
europepmc   +1 more source

Comparative effects of antimalarial drugs on oxidative phosphorylation, mitochondrial dynamics and mitophagy in <i>Plasmodium berghei</i>-infected mice. [PDF]

Toxicol Rep
Olanlokun JO, Yahaya OO, Babarinde CO, Oloke OM, Steenkamp P, Prinsloo G.   +5 more
europepmc   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source

Retraction: Coxiella burnetii in Humans and Ticks in Rural Senegal. [PDF]

PLoS Negl Trop Dis
PLOS Neglected Tropical Diseases Editors.
europepmc   +1 more source

Amodiaquine Hydrochloride [PDF]

, 2020
openaire   +1 more source

Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial. [PDF]

Lancet Infect Dis
Kamya MR, Nankabirwa JI, Ebong C, Asua V, Kiggundu M, Orena S, Okitwi M, Tukwasibwe S, Agaba B, Kyabayinze D, Opigo J, Rutazana D, Binagwa B, Mugwanya E, Babirye S, Sebikaari G, Condo PM, Appiah G, Nsobya SL, Conrad MD, Rosenthal PJ, Moriarty LF, Yeka A.   +22 more
europepmc   +1 more source

Spatio-temporal trends of artemisinin-based combination therapy efficacy from 2010 to 2024 in sub-Saharan Africa: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Bohissou FET, Nassa GJW, Sondo P, Rouamba T, Inoue J, Kaboré B, Asua V, Held J, Tinto H.   +8 more
europepmc   +1 more source

Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study.

Lancet Glob Health
Suresh J, Zimmermann M, Maiteki C, Stahlfeld A, Pratt A, Mathanga DP, Staedke SG, Laufer MK, Drakeley C, Bever C, Cohee LM.   +10 more
europepmc   +1 more source

Efficacy and Safety of Artesunate + Amodiaquine and Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Madagascar, 2020. [PDF]

Am J Trop Med Hyg
Harimanana A, Randriamiarinjatovo DNAL, Rakotomanga TA, Irinantenaina J, Moriarty LF, Laird V, Patel D, Abdallah RA, Zhiyong Z, Svigel SS, Kapesa L, Razafindrakoto J, Ralinoro F, Rason MA, Andriamananjara MN, Razanatsiorimalala S, Razafinjato C, Randrianarivelojosia M.   +17 more
europepmc   +1 more source

Chemoproteomics-based profiling elucidates the antimalarial effects of amodiaquine through disruption of glycolysis process in Plasmodium falciparum. [PDF]

Cell Commun Signal
Wang J, Wang C, Zhuge R, Tang H, Xia F, Zhang Y, Zhang J, Liu C, Wu J, Chen X, Gao P, Wang J.   +11 more
europepmc   +1 more source